Alert: New Earnings Report (5/2/24)-Blueprint Medicines Corp (NASDAQ: BPMC).
Blueprint Medicines Corp (NASDAQ: BPMC) has reported earnings for its first fiscal quarter (ending March 31) of $1.45 versus a loss $-2.15 for the same period a year ago. This performance was $2.66 better than […]